Annual Revenue
N/A
December 31, 2021
Summary
- IDRA annual revenue is not available.
Performance
IDRA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
$49.00 K
NaN%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly revenue is $49.00 thousand
Performance
IDRA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
$49.00 K
NaN%
September 30, 2022
Summary
- As of February 10, 2025, IDRA TTM revenue is $49.00 thousand
Performance
IDRA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
IDRA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | -70.1% | - |
IDRA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | at low | ||
| 5 y | 5-year | at high | at low | at high | at low | ||
| alltime | all time | -99.8% | -1100.8% | -99.9% | -100.0% |
Idera Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $49.00 K(-96.6%) | $49.00 K(-97.1%) |
| Dec 2019 | $1.45 M(+118.7%) | - | - |
| Jun 2019 | - | $1.45 M(+1362.6%) | $1.69 M(+155.6%) |
| Dec 2018 | $662.00 K(-26.6%) | $99.00 K(-31.7%) | $662.00 K(-10.1%) |
| Sep 2018 | - | $145.00 K(-11.0%) | $736.00 K(-2.5%) |
| Jun 2018 | - | $163.00 K(-36.1%) | $755.00 K(-3.1%) |
| Mar 2018 | - | $255.00 K(+47.4%) | $779.00 K(-13.6%) |
| Dec 2017 | $902.00 K(-94.4%) | $173.00 K(+5.5%) | $902.00 K(-94.4%) |
| Sep 2017 | - | $164.00 K(-12.3%) | $16.01 M(-1.0%) |
| Jun 2017 | - | $187.00 K(-50.5%) | $16.17 M(-0.7%) |
| Mar 2017 | - | $378.00 K(-97.5%) | $16.28 M(+0.5%) |
| Dec 2016 | $16.20 M(+6405.6%) | $15.28 M(+4631.0%) | $16.20 M(+1362.0%) |
| Sep 2016 | - | $323.00 K(+7.3%) | $1.11 M(+37.6%) |
| Jun 2016 | - | $301.00 K(+2.4%) | $805.00 K(+58.2%) |
| Mar 2016 | - | $294.00 K(+54.7%) | $509.00 K(+104.4%) |
| Dec 2015 | $249.00 K(+241.1%) | $190.00 K(+850.0%) | $249.00 K(+308.2%) |
| Sep 2015 | - | $20.00 K(+300.0%) | $61.00 K(-14.1%) |
| Jun 2015 | - | $5000.00(-85.3%) | $71.00 K(-31.7%) |
| Mar 2015 | - | $34.00 K(+1600.0%) | $104.00 K(+42.5%) |
| Dec 2014 | $73.00 K(+55.3%) | $2000.00(-93.3%) | $73.00 K(-2.7%) |
| Sep 2014 | - | $30.00 K(-21.1%) | $75.00 K(+44.2%) |
| Jun 2014 | - | $38.00 K(+1166.7%) | $52.00 K(+20.9%) |
| Mar 2014 | - | $3000.00(-25.0%) | $43.00 K(-8.5%) |
| Dec 2013 | $47.00 K(-7.8%) | $4000.00(-42.9%) | $47.00 K(-13.0%) |
| Sep 2013 | - | $7000.00(-75.9%) | $54.00 K(+8.0%) |
| Jun 2013 | - | $29.00 K(+314.3%) | $50.00 K(+2.0%) |
| Mar 2013 | - | $7000.00(-36.4%) | $49.00 K(-3.9%) |
| Dec 2012 | $51.00 K(-3.8%) | $11.00 K(+266.7%) | $51.00 K(+6.3%) |
| Sep 2012 | - | $3000.00(-89.3%) | $48.00 K(-2.0%) |
| Jun 2012 | - | $28.00 K(+211.1%) | $49.00 K(-9.3%) |
| Mar 2012 | - | $9000.00(+12.5%) | $54.00 K(+1.9%) |
| Dec 2011 | $53.00 K(-99.7%) | $8000.00(+100.0%) | $53.00 K(-95.2%) |
| Sep 2011 | - | $4000.00(-87.9%) | $1.10 M(-82.2%) |
| Jun 2011 | - | $33.00 K(+312.5%) | $6.19 M(-41.3%) |
| Mar 2011 | - | $8000.00(-99.2%) | $10.54 M(-34.6%) |
| Dec 2010 | $16.11 M(-53.3%) | $1.06 M(-79.2%) | $16.11 M(-36.2%) |
| Sep 2010 | - | $5.09 M(+16.0%) | $25.23 M(-5.4%) |
| Jun 2010 | - | $4.39 M(-21.4%) | $26.68 M(-21.0%) |
| Mar 2010 | - | $5.58 M(-45.2%) | $33.79 M(-2.1%) |
| Dec 2009 | $34.52 M | $10.18 M(+55.7%) | $34.52 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $6.54 M(-43.1%) | $30.65 M(-3.0%) |
| Jun 2009 | - | $11.50 M(+82.4%) | $31.61 M(+13.0%) |
| Mar 2009 | - | $6.30 M(-0.2%) | $27.98 M(+5.8%) |
| Dec 2008 | $26.45 M(+231.4%) | $6.32 M(-15.8%) | $26.45 M(+18.2%) |
| Sep 2008 | - | $7.50 M(-4.7%) | $22.37 M(+32.8%) |
| Jun 2008 | - | $7.87 M(+64.8%) | $16.84 M(+54.2%) |
| Mar 2008 | - | $4.77 M(+113.7%) | $10.92 M(+36.9%) |
| Dec 2007 | $7.98 M(+229.7%) | $2.23 M(+13.4%) | $7.98 M(+25.9%) |
| Sep 2007 | - | $1.97 M(+1.1%) | $6.34 M(+28.3%) |
| Jun 2007 | - | $1.95 M(+6.6%) | $4.94 M(+36.7%) |
| Mar 2007 | - | $1.83 M(+209.2%) | $3.61 M(+49.3%) |
| Dec 2006 | $2.42 M(-1.9%) | $591.50 K(+3.4%) | $2.42 M(-25.9%) |
| Sep 2006 | - | $572.10 K(-8.0%) | $3.27 M(+0.8%) |
| Jun 2006 | - | $622.00 K(-2.2%) | $3.24 M(+10.6%) |
| Mar 2006 | - | $636.00 K(-55.8%) | $2.93 M(+18.8%) |
| Dec 2005 | $2.47 M(+161.7%) | $1.44 M(+164.2%) | $2.47 M(+112.9%) |
| Sep 2005 | - | $544.80 K(+74.9%) | $1.16 M(+67.4%) |
| Jun 2005 | - | $311.50 K(+81.8%) | $692.10 K(+47.6%) |
| Mar 2005 | - | $171.30 K(+30.5%) | $468.80 K(-50.3%) |
| Dec 2004 | $942.60 K(+5.1%) | $131.30 K(+68.3%) | $942.70 K(+41.0%) |
| Sep 2004 | - | $78.00 K(-11.6%) | $668.70 K(-29.8%) |
| Jun 2004 | - | $88.20 K(-86.3%) | $952.40 K(-3.2%) |
| Mar 2004 | - | $645.20 K(-552.1%) | $984.00 K(+46.1%) |
| Dec 2003 | $896.60 K(-97.0%) | -$142.70 K(-139.5%) | $673.60 K(+106.7%) |
| Sep 2003 | - | $361.70 K(+201.9%) | $325.90 K(-98.8%) |
| Jun 2003 | - | $119.80 K(-64.2%) | $28.30 M(-2.4%) |
| Mar 2003 | - | $334.80 K(-168.3%) | $29.00 M(-1.9%) |
| Dec 2002 | $29.61 M(+2539.1%) | -$490.40 K(-101.7%) | $29.55 M(-3.9%) |
| Sep 2002 | - | $28.33 M(+3362.8%) | $30.76 M(+1095.9%) |
| Jun 2002 | - | $818.20 K(-7.7%) | $2.57 M(+20.1%) |
| Mar 2002 | - | $886.80 K(+23.2%) | $2.14 M(+70.7%) |
| Dec 2001 | $1.12 M(+328.5%) | $720.00 K(+390.1%) | $1.25 M(+134.6%) |
| Sep 2001 | - | $146.90 K(-62.1%) | $534.80 K(+37.9%) |
| Jun 2001 | - | $387.90 K(+848.4%) | $387.90 K(+848.4%) |
| Dec 2000 | $261.80 K(-72.9%) | - | - |
| Jun 2000 | - | $40.90 K(>+9900.0%) | $40.90 K(>+9900.0%) |
| Mar 2000 | - | $0.00 | $0.00 |
| Dec 1999 | $965.00 K(-78.6%) | - | - |
| Dec 1998 | $4.50 M(+14.0%) | - | - |
| Dec 1997 | $3.95 M(-1.5%) | - | - |
| Dec 1996 | $4.01 M | - | - |
FAQ
- What is the all time high annual revenue for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Idera Pharmaceuticals?
What is the all time high annual revenue for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual revenue is $34.52 M
What is Idera Pharmaceuticals quarterly revenue?
The current quarterly revenue of IDRA is $49.00 K
What is the all time high quarterly revenue for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly revenue is $28.33 M
What is Idera Pharmaceuticals TTM revenue?
The current TTM revenue of IDRA is $49.00 K
What is the all time high TTM revenue for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high TTM revenue is $34.52 M